Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Debt Ratio (2022 - 2025)

Historic Debt Ratio for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 0.86.

  • Phathom Pharmaceuticals' Debt Ratio rose 8982.28% to 0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86, marking a year-over-year increase of 8982.28%. This contributed to the annual value of 0.53 for FY2024, which is 5983.61% up from last year.
  • Per Phathom Pharmaceuticals' latest filing, its Debt Ratio stood at 0.86 for Q3 2025, which was up 8982.28% from 0.82 recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Debt Ratio high stood at 0.86 for Q3 2025, and its period low was 0.33 during Q4 2023.
  • Its 4-year average for Debt Ratio is 0.55, with a median of 0.53 in 2024.
  • Per our database at Business Quant, Phathom Pharmaceuticals' Debt Ratio plummeted by 4237.62% in 2023 and then soared by 8982.28% in 2025.
  • Over the past 4 years, Phathom Pharmaceuticals' Debt Ratio (Quarter) stood at 0.58 in 2022, then tumbled by 42.38% to 0.33 in 2023, then skyrocketed by 59.84% to 0.53 in 2024, then surged by 61.89% to 0.86 in 2025.
  • Its Debt Ratio stands at 0.86 for Q3 2025, versus 0.82 for Q2 2025 and 0.69 for Q1 2025.